Related Experiment Videos
Arrhythmogenic right ventricular cardiomyopathy: three cases
Kun-Tai Lee1, Wen-Ter Lai, Hsueh-Wei Yen
1Section of Cardiology, Department of Internal Medicine, Medical University Hospital, Kaohsiung, Taiwan. kuntai.lee@msa.hinet.net
The Kaohsiung Journal of Medical Sciences
|January 9, 2003
Summary
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a rare heart condition causing fibrofatty tissue replacement in the right ventricle. This study reviews ARVC
Area of Science:
- Cardiology
- Genetics
- Pathology
Background:
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a rare inherited heart muscle disease.
- It is characterized by fibrofatty replacement of the right ventricular myocardium.
- ARVC is a significant cause of sudden cardiac death in young individuals, particularly athletes.
Purpose of the Study:
- To describe the clinical manifestations of ARVC.
- To compare ARVC presentation in Chinese and Western populations.
- To review existing literature on ARVC.
Main Methods:
- Retrospective case series analysis.
- Literature review of previously reported ARVC cases.
- Clinical data compilation and comparative analysis.
Main Results:
- ARVC involves fibrofatty tissue replacement, primarily affecting the right ventricle.
- Abnormal right ventricular performance is a key feature.
- Clinical presentations may differ between Chinese and Western patients.
Conclusions:
- ARVC is a serious condition leading to malignant ventricular tachyarrhythmias and sudden cardiac death.
- Understanding ethnic variations in ARVC clinical manifestations is crucial for diagnosis and management.
- Further research is needed to elucidate the full spectrum of ARVC.